Clinical review: Low body weight mediates the relationship between HIV infection and low bone mineral density: A meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 12, 2007, Pages 4522-4528

  Bolland, Mark J ^a   Grey, Andrew B ^a   Gamble, Greg D ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

BODY MASS; BODY WEIGHT; BONE ATROPHY; BONE DENSITY; CROSS-SECTIONAL STUDY; EMBASE; FEMUR NECK; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LUMBAR SPINE; MEDLINE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SEX DIFFERENCE; WEIGHT CONTROL;

EID: 36848998860     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1660     Document Type: Article

References (55)

1. Amorosa V, Tebas P 2006 Bone disease and HIV infection. Clin Infect Dis 42:108-114
2. Brown TT, McComsey GA 2006 Osteopenia and osteoporosis in patients with HIV: a review of current concepts. Curr Infect Dis Rep 8:162-170
3. Brown TT, Qaqish RB 2006 Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165-2174
4. Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR 2006 Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy. Clin Endocrinol (Oxf) 65:191-197
5. Reid IR 2002 Relationships among body mass, its components, and bone. Bone 31:547-555
6. Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S 2001 Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 15:1275-1280
7. Cirelli A, Cirelli G, Balsamo G, Masciangelo R, Stasolla A, Marini M 2003 Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection. Ann Ital Med Int 18:238-245
8. Fernandez-Rivera J, Garcia R, Lozano F, Macias J, Garcia-Garcia JA, Mira JA, Corzo JE, Gomez-Mateos J, Rueda A, Sanchez-Burson J, Pineda JA 2003 Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials 4:337-346
9. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P 2003 Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482-490
10. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK 2004 Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292:191-201
11. Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS 2004 Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 48:39-48
12. Martin A, Smith DE, Carr A, Ringland C, Amin J, Emery S, Hoy J, Workman C, Doong N, Freund J, Cooper DA 2004 Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS 18:1029-1036
13. Tebas P, Yarasheski K, Henry K, Claxton S, Kane E, Bordenave B, Klebert M, Powderly WG 2004 Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection. AIDS Res Hum Retroviruses 20:589-594
14. McComsey GA, Ward DJ, Hessenthaler SM, Sension MG, Shalit P, Lonergan JT, Fisher RL, Williams VC, Hernandez JE 2004 Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis 38:263-270
15. Dolan SE, Kanter JR, Grinspoon S 2006 Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 91:2938-2945
16. Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR 2007 Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years. Clin Endocrinol (Oxf) 67:270-275
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB 2000 Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
18. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E 2004 Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 74:136-142
19. Lucas JA, Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, Reid IR 2005 Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 16:1641-1648
20. Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, Reid IR 2006 Determinants of vitamin D status in older men living in a subtropical climate. Osteoporos Int 17:1742-1748
21. Robbins J, Schott AM, Azari R, Kronmal R 2006 Body mass index is not a good predictor of bone density: results from WHI, CHS, and EPIDOS. J Clin Densitom 9:329-334
22. Ogden CL, Fryar CD, Carroll MD, Flegal KM 2004 Mean body weight, height, and body mass index, United States 1960-2002. Advance data from vital and health statistics, 347. Hyattsville, MD: National Center for Health Statistics
23. Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C 1994 Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503-1514
24. Lu Y, Fuerst T, Hui S, Genant HK 2001 Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int 12:438-444
25. Tothill P, Hannan WJ, Wilkinson S 2001 Comparisons between a pencil beam and two fan beam dual energy x-ray absorptiometers used for measuring total body bone and soft tissue. Br J Radiol 74:166-176
26. Hernandez Quero J, Ortego Centeno N, Munoz-Torres M, Martinez Perez MA, Higuera Torres-Puchol JM 1993 Alterations in bone turnover in HIV-positive patients. Infection 21:220-222
27. Lawal A, Engelson ES, Wang J, Heymsfield SB, Kotler DP 2001 Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS 15:278-280
28. Loiseau-Peres S, Delaunay C, Poupon S, Lespessailles E, Ballouche N, Arsac P, Benhamou CL 2002 Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine 69:482-485
29. Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J, Stracke H, Bretzel RG 2003 Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect 46:221-227
30. Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S 2001 Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS 15:975-982
31. Huang JS, Wilkie SJ, Sullivan MP, Grinspoon S 2001 Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting. J Clin Endocrinol Metab 86:3533-3539
32. Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63-F67
33. Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S 2004 Reduced bone density in HIV-infected women. AIDS 18:475-483
34. Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK 2001 Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 86:2020-2026
35. Knobel H, Guelar A, Vallecillo G, Nogues X, Diez A 2001 Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 15:807-808
36. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J 2003 Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17:1917-1923
37. Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC 2004 BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res 19:402-409
38. Brown TT, Ruppe MD, Kassner R, Kumar P, Kehoe T, Dobs AS, Timpone J 2004 Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab 89:1200-1206
39. Bonnet E, Delpierre C, Sommet A, Marion-Latard F, Herve R, Aquilina C, Labau E, Obadia M, Marchou B, Massip P, Perret B, Bernard J 2005 Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy. J Clin Densitom 8:287-292
40. Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M, Addesso V, Shane E 2005 Bone mass and mineral metabolism in HIV + postmenopausal women. Osteoporos Int 16:1345-1352
41. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE 2006 HIV infection and bone mineral density in middle-aged women. Clin Infect Dis 42:1014-1020
42. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS 2007 Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21:617-623
43. Prior JC, Burdge D, Mann E, Milner R 2005 Bone density and fracture risk in women who are HIV positive: a case population-based control study with Canadian muliticentre osteoporosis study. J Bone Miner Res 20(Suppl 1):S269 (Abstract SU347)
44. Prior J, Burdge D, Maan E, Milner R, Hankins C, Klein M, Walmsley S 2007 Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporos Int 18:1345-1353
45. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP 2000 Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 15:710-720
46. Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR 2002 Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) 56:703-711
47. Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B, Oden A, Zethraeus N, Pfleger B, Khaltaev N 2005 Assessment of fracture risk. Osteoporos Int 16:581-589
48. Istvan JA, Cunningham TW, Garfinkel L 1992 Cigarette smoking and body weight in the Cancer Prevention Study I. Int J Epidemiol 21:849-853
49. Blanchard R, Bogaert AF 1996 Biodemographic comparisons of homosexual and heterosexual men in the Kinsey Interview Data. Arch Sex Behav 25:551-579
50. Beren SE, Hayden HA, Wilfley DE, Grilo CM 1996 The influence of sexual orientation on body dissatisfaction in adult men and women. Int J Eat Disord 20:135-141
51. Ryan H, Wortley PM, Easton A, Pederson L, Greenwood G 2001 Smoking among lesbians, gays, and bisexuals: a review of the literature. Am J Prev Med 21:142-149
52. Carr A, Miller J, Eisman JA, Cooper DA 2001 Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 15:703-709
53. Lambert PC, Sutton AJ, Abrams KR, Jones DR 2002 A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 55:86-94
54. American Association of Clinical Endocrinologists 2003 Medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endo Pract 9:545-564
55. National Osteoporosis Foundation 2003 Physician's guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation